doxazosin

Generic: doxazosin

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 4 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-2172
Product ID 50090-2172_e184efc2-7240-4202-9778-f8d9d1fdf9ca
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202824
Listing Expiration 2026-12-31
Marketing Start 2015-04-22

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500902172
Hyphenated Format 50090-2172

Supplemental Identifiers

RxCUI
197625 197626 197627 197628
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number ANDA202824 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (50090-2172-0)
  • 100 TABLET in 1 BOTTLE (50090-2172-1)
  • 90 TABLET in 1 BOTTLE (50090-2172-2)
source: ndc

Packages (3)

50090-2172-0 30 TABLET in 1 BOTTLE (50090-2172-0) 50090-2172-1 100 TABLET in 1 BOTTLE (50090-2172-1) 50090-2172-2 90 TABLET in 1 BOTTLE (50090-2172-2)

Ingredients (1)

doxazosin mesylate (4 mg/1)

Linked Drug Pages (1)

Doxazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e184efc2-7240-4202-9778-f8d9d1fdf9ca", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197625", "197626", "197627", "197628"], "spl_set_id": ["4034fb6d-f55d-4df0-b500-d6a413591f6e"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-2172-0)", "package_ndc": "50090-2172-0", "marketing_start_date": "20151023"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (50090-2172-1)", "package_ndc": "50090-2172-1", "marketing_start_date": "20151023"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-2172-2)", "package_ndc": "50090-2172-2", "marketing_start_date": "20180613"}], "brand_name": "Doxazosin", "product_id": "50090-2172_e184efc2-7240-4202-9778-f8d9d1fdf9ca", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "50090-2172", "generic_name": "Doxazosin", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "ANDA202824", "marketing_category": "ANDA", "marketing_start_date": "20150422", "listing_expiration_date": "20261231"}